The rise in the share price came after the company announced that it has received World Health Organisation (WHO) prequalification approval for Albendazole Active Pharmaceutical Ingredient (API). Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
